Have a feature idea you'd love to see implemented? Let us know!

BSX Boston Scientific Corp

Price (delayed)

$86.7

Market cap

$127.68B

P/E Ratio

69.92

Dividend/share

N/A

EPS

$1.24

Enterprise value

$135.33B

Boston Scientific Corporation, doing business as Boston Scientific, is a manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, ...

Highlights
The EPS has soared by 107% YoY and by 3.3% from the previous quarter
Boston Scientific's net income has surged by 100% YoY and by 3% QoQ
The P/E is 18% above the last 4 quarters average of 59.3 but 4.6% below the 5-year quarterly average of 73.3
Boston Scientific's debt has increased by 17% YoY

Key stats

What are the main financial stats of BSX
Market
Shares outstanding
1.47B
Market cap
$127.68B
Enterprise value
$135.33B
Valuations
Price to book (P/B)
6.26
Price to sales (P/S)
8.37
EV/EBIT
55.85
EV/EBITDA
37.07
EV/Sales
8.89
Earnings
Revenue
$15.23B
EBIT
$2.42B
EBITDA
$3.65B
Free cash flow
$1.87B
Per share
EPS
$1.24
Free cash flow per share
$1.27
Book value per share
$13.86
Revenue per share
$10.35
TBVPS
$11.76
Balance sheet
Total assets
$37.11B
Total liabilities
$16.5B
Debt
$10.57B
Equity
$20.37B
Working capital
$3.42B
Liquidity
Debt to equity
0.52
Current ratio
1.61
Quick ratio
0.95
Net debt/EBITDA
2.1
Margins
EBITDA margin
24%
Gross margin
69%
Net margin
12%
Operating margin
16.2%
Efficiency
Return on assets
5.1%
Return on equity
9.3%
Return on invested capital
12.9%
Return on capital employed
7.7%
Return on sales
15.9%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

BSX stock price

How has the Boston Scientific stock price performed over time
Intraday
1%
1 week
2.62%
1 month
4.9%
1 year
65.46%
YTD
49.97%
QTD
3.46%

Financial performance

How have Boston Scientific's revenue and profit performed over time
Revenue
$15.23B
Gross profit
$10.5B
Operating income
$2.47B
Net income
$1.83B
Gross margin
69%
Net margin
12%
Boston Scientific's net income has surged by 100% YoY and by 3% QoQ
Boston Scientific's net margin has surged by 76% YoY
Boston Scientific's operating income has increased by 35% YoY
BSX's operating margin is up by 19% year-on-year but it is down by 3% since the previous quarter

Growth

What is Boston Scientific's growth rate over time

Valuation

What is Boston Scientific stock price valuation
P/E
69.92
P/B
6.26
P/S
8.37
EV/EBIT
55.85
EV/EBITDA
37.07
EV/Sales
8.89
The EPS has soared by 107% YoY and by 3.3% from the previous quarter
The P/E is 18% above the last 4 quarters average of 59.3 but 4.6% below the 5-year quarterly average of 73.3
The stock's price to book (P/B) is 61% more than its 5-year quarterly average of 3.9 and 30% more than its last 4 quarters average of 4.8
The equity has grown by 12% YoY and by 2.2% from the previous quarter
BSX's P/S is 55% above its 5-year quarterly average of 5.4 and 29% above its last 4 quarters average of 6.5
The revenue has increased by 14% YoY and by 3.5% from the previous quarter

Efficiency

How efficient is Boston Scientific business performance
The return on assets has surged by 96% year-on-year
The return on equity has surged by 94% year-on-year
BSX's ROIC is up by 30% YoY
The ROS has increased by 20% YoY but it has decreased by 3.6% from the previous quarter

Dividends

What is BSX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for BSX.

Financial health

How did Boston Scientific financials performed over time
Boston Scientific's total assets is 125% more than its total liabilities
BSX's quick ratio has surged by 70% year-on-year
BSX's current ratio is up by 25% year-on-year but it is down by 3% since the previous quarter
Boston Scientific's debt is 48% lower than its equity
Boston Scientific's debt has increased by 17% YoY
The equity has grown by 12% YoY and by 2.2% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from and Sharadar.